United States · FDA National Drug Code directory

Slate Run Pharmaceuticals, LLC

Labeler · 112 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 70436-058_1b0de43f-05c2-aed6-e063-6394a90ac5df

Bupropion Hydrochloride SR

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-059_1b0de43f-05c2-aed6-e063-6394a90ac5df

Bupropion Hydrochloride SR

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-060_1b0de43f-05c2-aed6-e063-6394a90ac5df

Bupropion Hydrochloride SR

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-010_1b0d6505-54e6-a28f-e063-6294a90aae71

Bupropion Hydrochloride XL

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-011_1b0d6505-54e6-a28f-e063-6294a90aae71

Bupropion Hydrochloride XL

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-156_45be0b2e-7ae1-42d2-e063-6394a90a1da6

Cilostazol

TABLET / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-157_45be0b2e-7ae1-42d2-e063-6394a90a1da6

Cilostazol

TABLET / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-112_20cd9789-700a-5fa0-e063-6394a90a5d0d

Cisatracurium besylate

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-113_14793b7b-0e90-7b75-e063-6394a90a9c5a

Cisatracurium besylate

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-114_20cd9789-700a-5fa0-e063-6394a90a5d0d

Cisatracurium besylate

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-105_31c60f0f-f81b-a187-e063-6394a90aa39d

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-106_31c60f0f-f81b-a187-e063-6394a90aa39d

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-107_31c60f0f-f81b-a187-e063-6394a90aa39d

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-012_4dfe07e0-b3f0-b219-e063-6394a90aa4dc

Desvenlafaxine

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-013_4dfe07e0-b3f0-b219-e063-6394a90aa4dc

Desvenlafaxine

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-036_4dfe07e0-b3f0-b219-e063-6394a90aa4dc

Desvenlafaxine

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-147_4c2eae9b-279f-0604-e063-6394a90aaf35

Dicyclomine Hydrochloride

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-191_584a0d75-656b-7918-e063-6294a90a278e

Diltiazem Hydrochloride

CAPSULE, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-192_584a0d75-656b-7918-e063-6294a90a278e

Diltiazem Hydrochloride

CAPSULE, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-193_584a0d75-656b-7918-e063-6294a90a278e

Diltiazem Hydrochloride

CAPSULE, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-195_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-196_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-197_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-198_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-199_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-200_58494981-80ca-63f9-e063-6294a90aef59

Diltiazem Hydrochloride

TABLET, EXTENDED RELEASE / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-026_4a613f2d-85b3-d45c-e063-6294a90adb93

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-027_4a613f2d-85b3-d45c-e063-6294a90adb93

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-162_4a614df8-4e1d-d610-e063-6294a90a7d7c

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

United States · Source reference 70436-163_4a614df8-4e1d-d610-e063-6294a90a7d7c

Eptifibatide

INJECTION / Slate Run Pharmaceuticals, LLC

Browse companies in United States →